Tiotropium in chronic obstructive pulmonary disease – a review of clinical development

BACKGROUND: Bronchodilators are the mainstay of pharmacological treatment in chronic obstructive pulmonary disease (COPD), and long-acting muscarinic antagonist (LAMA) monotherapy is recommended as initial treatment for Global Initiative for Chronic Obstructive Lung Disease (GOLD) groups B, C, and D...

Descripción completa

Detalles Bibliográficos
Autores principales: Anzueto, Antonio, Miravitlles, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389564/
https://www.ncbi.nlm.nih.gov/pubmed/32727455
http://dx.doi.org/10.1186/s12931-020-01407-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389564/
https://www.ncbi.nlm.nih.gov/pubmed/32727455
http://dx.doi.org/10.1186/s12931-020-01407-y

Ejemplares similares